Sunflower Therapeutics
Sunflower Therapeutics is a startup headquartered in Hingham, United States, founded in 2022. It has raised at least $2.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Sunflower Therapeutics has raised at least $2.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Sunflower Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Hingham
Related
Questions and answers
What does Sunflower Therapeutics do?
Sunflower Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Sunflower Therapeutics raised?
At least $2.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Sunflower Therapeutics based?
Sunflower Therapeutics is headquartered in Hingham, United States.
When was Sunflower Therapeutics founded?
Sunflower Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.